Inhalation Sciences (ISAB) has appointed Paolo Raffaelli as its new Chief Commercial Officer (CCO). Mr. Raffaelli has extensive experience driving international sales in a wide range of medical device companies and takes up his position on December 14, 2020. The new CCO will be responsible for driving ISAB sales in Europe, the US and other international markets. He will have overall responsibility for Sales and Marketing activities, with a primary focus on account targeting. Paolo Raffaelli has over 20 years' executive experience in the life science and medical device industry, with extensive sales and marketing management experience, across European and international markets and he has been based in Stockholm, Brussels and the US.